logo
Select company
Select metric
$ 518KNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
37
Sector
67
Industry
78
History
80
$ 1.75Close
$ 0.36 - $ 2.11 52-Week Range
Ticker Information

Ticker

IVVD

Company Name

INVIVYD INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INVIVYD INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IVVD - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 518K
3/31/2025$ 635K
12/31/2024$ 39.93M
9/30/2024$ 40.05M
6/30/2024$ 40.02M
3/31/2024$ 40.03M
12/31/2023$ 1.19M
9/30/2023$ 1.04M
6/30/2023$ 1.2M
3/31/2023$ 1M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INVIVYD INC's latest trailing twelve months (TTM) CF - Equity stands at $ -421K.
  • Over the past 5 years, INVIVYD INC's average CF - Equity has been $ 71.78M.
  • The median CF - Equity for INVIVYD INC during this period was $ 1.2M
  • INVIVYD INC reached its highest CF - Equity over the past 5 years at $ 328.07M.
  • The lowest CF - Equity recorded by INVIVYD INC in the same timeframe $ -421K

INVIVYD INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
CELU : CELULARITY INC $ 3.53MDOMH : DOMINARI HOLDINGS INC $ 15.86MCSBR : CHAMPIONS ONCOLOGY INC $ 344KSPRO : SPERO THERAPEUTICS INC $ 0MGX : METAGENOMI INC $ -383KPLX : PROTALIX BIOTHERAPEUTICS INC $ 12.81MFBIO : FORTRESS BIOTECH INC $ 9.29MWHWK : WHITEHAWK THERAPEUTICS INC $ 94.48MICCC : IMMUCELL CORP $ 4.38MHYFT : MINDWALK HOLDINGS CORP $ 8.47M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

IVVD - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -421K

Minimum

Jun 30, 2021

$ 328.07M

Maximum

Jun 30, 2022

$ 71.78M

Average

$ 1.2M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 130.54K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 130.54K
median$ 0
std$ 17.65M